SCHEMBL6002502

SCHEMBL6002502

Clc1ccc(-c2n[c]c[nH]2)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.46
KMO O15229 2/20 0.42
HRH1 P35367 1/20 0.41
CYP1B1 Q16678 1/20 0.41
NPY5R Q15761 4/20 0.41
NOTUM Q6P988 2/20 0.41
IKBKB O14920 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
ALOX12 P18054 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17626003 0.79 KDM4E (0.41) NPY5RNOTUMIKBKBKDM4EMAPT
SCHEMBL2650383 0.76 IDO1 (0.49) HRH1NPY5RNOTUMKDM4EALDH1A1
SCHEMBL28536153 0.74 APP (0.46) KDM4EMAPTALDH1A1GAAIDO1
SCHEMBL4044851 0.73 CYP11B1 (0.45) CYP1B1NOTUMIKBKBKDM4EMAPT
SCHEMBL4047558 0.71 DGAT1 (0.37) CYP1B1IKBKBMAPTALDH1A1NPC1
SCHEMBL28536156 0.71 NISCH (0.47) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL4049587 0.71 ALDH1A1 (0.41) KDM4EMAPTALDH1A1NPC1RAB9A
SCHEMBL2652005 0.71 SMN1; SMN2 (0.38) NOTUMKDM4EMAPTALDH1A1NPC1
SCHEMBL4046324 0.70 KMO (0.40) KMONOTUMALDH1A1NPC1PKM
SCHEMBL29142667 0.70 BRD4 (0.43) AHRKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed